(Title of the Thesis)*
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
HETEROCYCLIC COMPOUND: a REVIEW Tushar P
International Standard Serial Number (ISSN): 2249-6807 International Journal of Institutional Pharmacy and Life Sciences 10 (3): May-June 2020 INTERNATIONAL JOURNAL OF INSTITUTIONAL PHARMACY AND LIFE SCIENCES Pharmaceutical Sciences Review Article……!!! Receive d: 04-04-2020; Re vis ed: 20-04-2020; Acce pte d: 01-05-2020 HETEROCYCLIC COMPOUND: A REVIEW Tushar P. Patil*, Amol S. Chaudhari, Harshal L. Tare TSPM's, Trimurti Institute of Pharmacy, Jalgaon, Maharashtra, India. Keywords: ABSTRACT Heterocyclic compound, Heterocyclic compound constitute the largest and most varied organic compound, cyclic family of organic compound. Today there are a lot of and non-cyclic. heterocyclic compounds are known, day by day the number is For Correspondence: increasing rapidly due to the enormous synthetic research and Tushar P. Patil also there synthetic utility. Heterocyclic compounds have a TSPM's, Trimurti Institute role in most fields of science such as medicinal chemistry, of Pharmacy, Jalgaon, Maharashtra, India. biochemistry also another area of science. The heterocyclic compounds are of very must interest in daily life. Heterocyclic compound have one or more hetero atoms in there structure. They may be cyclic or non-cyclic in nature. 18 Full Text Available On www.ijipls.com International Standard Serial Number (ISSN): 2249-6807 INTRODUCTION: A heterocyclic compound or ring structure is a cyclic compound that has atoms of least two different elements as members of its ring. Heterocyclic chemistry dealing with the synthesis, properties, and applications of these heterocycles Heterocyclic compounds include all of the nucleic acids, the majority of drugs, most biomass and many natural and synthetic dyes. The heterocyclic compounds are mainly interest in medicinal chemistry. -
Supplementary Information Cocrystal Design by Network-Based Link Prediction
Electronic Supplementary Material (ESI) for CrystEngComm. This journal is © The Royal Society of Chemistry 2019 Supplementary Information Cocrystal design by network-based link prediction Jan-Joris Devogelaer, Sander J.T. Brugman, Hugo Meekes, Paul Tinnemans, Elias Vlieg, René de Gelder Table of Contents S1 Materials and syntheses page 1 S2 Single-crystal X-ray structure determinations, ORTEP plots and H-Bonding page 6 a) CCDC 1940959 = p1812d: 4,4’-bipyridine + resorcinol b) CCDC 1940950 = p1823c: 1,2-di(4-pyridyl)ethylene + 4-aminobenzoic acid c) CCDC 1940956 = p1823a: 1,2-di(4-pyridyl)ethylene + 4-aminobenzoic acid dihydrate d) CCDC 1940954 = p1907a: 1,2-di(4-pyridyl)ethylene + sebacic acid e) CCDC 1940949 = p1818a: 4,4’-bipyridine + suberic acid f) CCDC 1940953 = p1922b: 1,2-di(4-pyridyl)ethylene + oxalic acid g) CCDC 1940955 = p1914b: 1,2-di(4-pyridyl)ethylene + oxalic acid dihydrate i) CCDC 1940951 = p1908a: 1,2-bis(4-pyridyl)ethane + salicylic acid j) CCDC 1940958 = p1926b: 1,2-di(4-pyridyl)ethylene + 4-nitrobenzoic acid k) CCDC 1940952 = p1910a: 1,2-di(4-pyridyl)ethylene + phthalic acid l) CCDC 1940957 = p1913a: 1,2-di(4-pyridyl)ethylene + malonic acid S3 Top 100 predictions of the scoring method page 17 S4 Predefined lists of common solvents and gases page 21 S1 - Materials and syntheses We first present the materials in Table S1, after which we discuss the protocol used to obtain crystals suitable for single-crystal X-ray diffraction. Besides the two-component structures shown in Table 2, an additional cocrystal dihydrate (c) and salt dihydrate (g) were found. -
The 67Th Southeastern and 71St Southwest Regional Meeting of the American Chemical Society
The 67th Southeastern and 71st Southwest Regional Meeting of the American Chemical Society November 4-7, 2015 Abby Parrill-Baker, Program Chair WEDNESDAY MORNING Cook Convention Center L-2 General Biological Chemistry S. Pedigo, Organizer, Presiding 8:00 1. Hydroxychalcones as inhibitors of Streptococcus mutans biofilms. B. Nijampatnam, H. Wu, S.E. Velu 8:20 2. F420 cofactor dependent glucose-6-phosphate dehydrogenase from Mycobacterium tuberculosis: Kinetic and biophysical characterization of wild-type enzyme and a His40 mutant. M. Oyugi, G. Bashiri, E. Baker, K.L. Johnson-Winters 8:40 3. A small molecule screen identifies a natural product that disrupts the fungal cell wall integrity pathway by targeting Hsp90. S. Tripathi, Q. Feng, M. Jacob, X. Li, A. Clark, A. Agarwal 9:00 4. Development of high-throughput screening of WecA for identification of novel antibacterial agents. S. Siricilla, K. Mitachi, M. Kurosu 9:20 5. Investigating enzymatic resistance to fosfomycin by FosB in Gram-positive bacteria. M.E. Keithly, M.K. Thompson, D.F. Stec, J. Harp, M.V. Voehler, W.J. Chazin, R.N. Armstrong 9:40 6. Metabolomic analysis of volatile organic compounds emitted from decomposing human cadavers. D.C. Haines, T. Deyne 10:00 7. Analysis of site directed mutants of diacylglycerol kinase-β by LC-MS/MS and bi-substrate kinetics. T.T. Pham, D.L. Baker 10:20 Intermission. 10:40 8. nNav1.5 blockers for breast cancer metastasis therapy. S. Dutta, S. Roger, K. Selander, S.E. Velu, W. Brouillette 11:00 9. Analysis of the bi-substrate kinetics of sphingosine kinase-1 inhibitors.